Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kerna Ventures is a venture capital firm founded in 2022 and based in the United States. The firm manages a portfolio of 13 companies and focuses on early-stage investments in life sciences and technology. Kerna Ventures specifically targets startups emerging from academic research institutions.
Kerna Ventures invests between $500K and $5M in pre-seed, seed, and seed-plus stages. The firm primarily focuses on sectors such as genome engineering, quantum computing, and computational biology, aiming to support startups with significant growth potential.
Notable companies in Kerna Ventures' portfolio include GenEdit, a UC Berkeley spin-out developing nanoparticles for genetic material delivery; Axent, which focuses on stem cell therapies; Nodal Therapeutics, known for its therapy delivery platform for autoimmune diseases; and Pasqal, specializing in quantum computing for drug design.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.